New data reinforce rosnilimab’s efficacy profile in rheumatoid arthritis (RA) with deepening of clinical responses, including CDAI remission, ...

The poster will be made available on the Presentations & Research page of Unicycive’s website following the poster ...

Benjamin Ball Associates, a London-based executive coaching and presentation training firm, has reported strengthened client feedback and announced refinements to its leadership and communication ...

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that an abstract highlighting data on Vanoglipel (DA-1241), a ...

Finding the budget, time, and resources to properly advertise as a small-to-medium-sized business (SMB) can be a daunting task. Pomelli, an AI experiment from Google Labs in collaboration with Google ...

ORLANDO, FLORIDA / ACCESS Newswire / October 30, 2025 / RedChip Companies will host an investor webinar with Connect Biopharma Holdings Limited (Nasdaq:CNTB) (Connect Biopharma, Connect or the Company ...

American Water Works Company, Inc. ( NYSE: AWK) M&A Call October 27, 2025 8:30 AM EDT Good morning, everyone. Welcome to today's conference call to discuss the combination of American Water and ...

Discover how Tim Bird and Mary Mclaughlin built Cheshire Cat Pubs & Inns into a £10.6m+ business with seven unique pubs.

Strong operating performance delivered double-digit growth on both the top and bottom lineRaising full year 2025 guidance and issuing full year 2026 guidanceAnnounces business combination with Husky ...

If your company is hiring less and changing corporate messaging, it could be a sign of an upcoming layoff, according to ...

Ladies and gentlemen, welcome to The Navigator Company conference call and webcast for the third quarter and 9 months results. Joining us today are the following directors: Antonio Redondo, Fernando ...

Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel ...